Exploratory study of individual differences in the weight loss effect of dietary intervention on obese people [Trial No. g2022002]

Not Applicable

• Conditions: Healthy adults

• Registration Number: JPRN-UMIN000048190
• Lead Sponsor: Macromill,Inc.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-07-10
• Study Completion: 2022-12-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Pending
• Sex: Male
• Target Recruitment: 60

Inclusion Criteria

Not provided

Exclusion Criteria

(1) Currently receiving drug treatment due to some chronic disease (users of drugs that suppress allergic symptoms such as allergic rhinitis can be included in the subjects). (2) Subjects who have a history or current history of diseases such as liver disease, renal disease, respiratory disease, endocrine disorder, metabolic disorder, organ disorder, gout, rheumatism, autoimmune disease, mental disease, cancer, infectious disease, and arrhythmia. (3) Alcoholic drinkers (alcohol equivalent 60g / day or more) (4) Subjects with a history of gastrointestinal resection (excluding cecal resection) (5) Subjects who collected 200 mL of blood (donated blood, etc.) within 1 month or 400 mL or more within 3 months of the start of this study. (6) Skin diseases (atopic dermatitis, acne vulgaris, psoriasis, etc.) on face. (7) Subjects who use medical external medicine on the face. (8) Excessive sunburn on the face. (9) Subjects who have metal allergies, pacemakers, etc. in their bodies. (10) Subjects who plan to participate in other clinical trials during the trial participation period. (11) Subjects who are not day shifts such as night shifts and rotation shifts (12) Subjects who have felt sick at the time of blood collection, or those who have difficulty in collecting blood because the blood vessels in the arm are difficult to see. (13) Subjects who have a history of drug dependence, alcohol dependence, or current medical history. (14) During the two weeks prior to the visit to the test site, the patient or his / her family members had mild wind symptoms such as fever, cough, and sore throat (symptoms lasted for 4 days or more), high fever, dyspnea, and strong fatigue. Those who have or are currently having dysgeusia or olfactory dysfunction. (15) Those who plan to travel or travel for more than 2 weeks during the test period. (16) Those deemed inappropriate to participate in this study by the principle PI

Study & Design

• Study Type: Interventional
• Study Design: Not specified